NUMBRINO

Product NDC: 81665-300
11-digit product format: 816650300
Labeler code: 81665
Product ID: 81665-300_b722df62-ac8d-49c0-b357-c814b89471fe
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: cocaine hydrochloride nasal
Dosage form: SOLUTION
Route: TOPICAL
Labeler: OMNIVIUM PHARMACEUTICALS LLC.
Application: NDA209575
Marketing category: NDA
Marketing start: 2024-06-19
Substance: COCAINE HYDROCHLORIDE
Active strength: 40 mg/mL
DEA schedule: CII
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N209575-001	NUMBRINO	COCAINE HYDROCHLORIDE	4%	SOLUTION / NASAL		RLD, RS	2020-01-10

Orange Book patents#

Current patent rows page 1 of 1 · 18 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N209575-001	10016407	2037-02-07	U-2225		2023-08-28
N209575-001	10016407	2037-02-07	U-2226		2023-08-28
N209575-001	10016407	2037-02-07	U-2329		2023-08-28
N209575-001	10149843	2037-02-07	U-2478		2023-08-28
N209575-001	10149843	2037-02-07	U-2479		2023-08-28
N209575-001	10231961	2037-02-07		Drug product	2023-08-28
N209575-001	10413505	2037-02-07	U-3014		2023-08-28
N209575-001	10420760	2037-02-07	U-2478		2023-08-28
N209575-001	10857095	2037-02-07	U-3014		2023-08-28
N209575-001	10894012	2037-02-07	U-3014		2023-08-28
N209575-001	10933060	2037-02-07	U-2478		2023-08-28
N209575-001	10933060	2037-02-07	U-3014		2023-08-28
N209575-001	10973811	2037-02-07	U-3680		2023-08-28
N209575-001	11040032	2037-02-07		Drug product	2023-08-28
N209575-001	9867815	2037-02-07	U-2225		2023-08-28
N209575-001	9867815	2037-02-07	U-2226		2023-08-28
N209575-001	9867815	2037-02-07	U-2227		2023-08-28
N209575-001	9867815	2037-02-07	U-2329		2023-08-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N209575-001	NUMBRINO	4%	SOLUTION / NASAL		2020-01-10	`c0c555d07b60…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N209575-001	NUMBRINO	4%	SOLUTION / NASAL	RLD, RS	2020-01-10	`a50c72e98297…`

Observed Orange Book patent history#

Patent history page 1 of 10 · 396 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N209575-001	10016407	2037-02-07	U-2225		2023-08-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209575-001	10016407	2037-02-07	U-2226		2023-08-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209575-001	10016407	2037-02-07	U-2329		2023-08-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209575-001	10149843	2037-02-07	U-2478		2023-08-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209575-001	10149843	2037-02-07	U-2479		2023-08-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209575-001	10231961	2037-02-07		Drug product	2023-08-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209575-001	10413505	2037-02-07	U-3014		2023-08-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209575-001	10420760	2037-02-07	U-2478		2023-08-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209575-001	10857095	2037-02-07	U-3014		2023-08-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209575-001	10894012	2037-02-07	U-3014		2023-08-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209575-001	10933060	2037-02-07	U-2478		2023-08-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209575-001	10933060	2037-02-07	U-3014		2023-08-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209575-001	10973811	2037-02-07	U-3680		2023-08-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209575-001	11040032	2037-02-07		Drug product	2023-08-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209575-001	9867815	2037-02-07	U-2225		2023-08-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209575-001	9867815	2037-02-07	U-2329		2023-08-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209575-001	9867815	2037-02-07	U-2227		2023-08-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209575-001	9867815	2037-02-07	U-2226		2023-08-28	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N209575-001	10016407	2037-02-07	U-2225		2023-08-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209575-001	10016407	2037-02-07	U-2226		2023-08-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209575-001	10016407	2037-02-07	U-2329		2023-08-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209575-001	10149843	2037-02-07	U-2478		2023-08-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209575-001	10149843	2037-02-07	U-2479		2023-08-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209575-001	10231961	2037-02-07		Drug product	2023-08-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209575-001	10413505	2037-02-07	U-3014		2023-08-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209575-001	10420760	2037-02-07	U-2478		2023-08-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209575-001	10857095	2037-02-07	U-3014		2023-08-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209575-001	10894012	2037-02-07	U-3014		2023-08-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209575-001	10933060	2037-02-07	U-2478		2023-08-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209575-001	10933060	2037-02-07	U-3014		2023-08-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209575-001	10973811	2037-02-07	U-3680		2023-08-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209575-001	11040032	2037-02-07		Drug product	2023-08-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209575-001	9867815	2037-02-07	U-2225		2023-08-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209575-001	9867815	2037-02-07	U-2329		2023-08-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209575-001	9867815	2037-02-07	U-2227		2023-08-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209575-001	9867815	2037-02-07	U-2226		2023-08-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N209575-001	10016407	2037-02-07	U-2225		2023-08-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209575-001	10016407	2037-02-07	U-2226		2023-08-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209575-001	10016407	2037-02-07	U-2329		2023-08-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209575-001	10149843	2037-02-07	U-2478		2023-08-28	`011fe1cb6892…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N209575-001	NCE	2022-12-14	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N209575-001	NP	2023-01-10	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N209575-001	NCE	2022-12-14	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N209575-001	NP	2023-01-10	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N209575-001	NCE	2022-12-14	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N209575-001	NP	2023-01-10	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	N209575-001	NCE	2022-12-14	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N209575-001	NP	2023-01-10	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N209575-001	NCE	2022-12-14	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N209575-001	NP	2023-01-10	`782e0a99824c…`
2023-12-20 04:57 UTC	2023-12	N209575-001	NP	2023-01-10	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N209575-001	NP	2023-01-10	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N209575-001	NP	2023-01-10	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N209575-001	NP	2023-01-10	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N209575-001	NP	2023-01-10	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N209575-001	NP	2023-01-10	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N209575-001	NCE	2022-12-14	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N209575-001	NP	2023-01-10	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N209575-001	NCE	2022-12-14	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N209575-001	NP	2023-01-10	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N209575-001	NCE	2022-12-14	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N209575-001	NP	2023-01-10	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N209575-001	NCE	2022-12-14	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N209575-001	NP	2023-01-10	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N209575-001	NCE	2022-12-14	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N209575-001	NP	2023-01-10	`cb3db0bc1861…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: NUMBRINO
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
COCAINE HYDROCHLORIDE	40 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
XH8T8T6WZH	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1995288	Internal RxNorm lookup
2272608	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
d724b5b4-6654-4bf5-9eed-e2c7943084ed	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
dc803e48-5aa8-4a87-8ab4-fcff7feb5dd5	Product name	1	20200610
8e5656e6-cd09-45b0-8d65-fbeaa5f1dc4e	Product name	1	20180220

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
81665-300-02	NUMBRINO	1 in 1 CARTON	SOLUTION	1		3
81665-300-02	NUMBRINO	4 mL in 1 BOTTLE, GLASS	SOLUTION	4		3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
81665-300-02	ML - Milliliter	81665-300	611db05a-e72e-4a2c-a625-dfaca0827305	1	2024-07-12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
81665-300	NUMBRINO (COCAINE HYDROCHLORIDE NASAL) SOLUTION [OMNIVIUM PHARMACEUTICALS LLC.]	2	Current NDC, 2 package rows	20240622_d724b5b4-6654-4bf5-9eed-e2c7943084ed.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
NUMBRINO	COCAINE HYDROCHLORIDE NASAL	OMNIVIUM PHARMACEUTICALS LLC.	d724b5b4-6654-4bf5-9eed-e2c7943084ed	2026-01-12	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 209575 application number: NDA209575 ndc (product): 81665-300
cocaine hydrochloride nasal	COCAINE HYDROCHLORIDE NASAL	OMNIVIUM PHARMACEUTICALS LLC.	4e3b2f6b-1b57-40bc-872b-01c0a3c7986e	2023-09-24	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 209575 application number: NDA209575

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
XH8T8T6WZH	COCAINE HYDROCHLORIDE	53-21-4	COCAINE HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1995288	cocaine hydrochloride 4 % Nasal Solution	PSN	d724b5b4-6654-4bf5-9eed-e2c7943084ed	3
2272608	NUMBRINO 4 % (40 MG/ML) Nasal Solution	PSN	d724b5b4-6654-4bf5-9eed-e2c7943084ed	3
2272608	cocaine hydrochloride 40 MG/ML Nasal Solution [Numbrino]	SBD	d724b5b4-6654-4bf5-9eed-e2c7943084ed	3
1995288	cocaine hydrochloride 40 MG/ML Nasal Solution	SCD	d724b5b4-6654-4bf5-9eed-e2c7943084ed	3
1995288	cocaine hydrochloride 4 % Nasal Solution	SY	d724b5b4-6654-4bf5-9eed-e2c7943084ed	3
2272608	Numbrino 40 MG/ML Nasal Solution	SY	d724b5b4-6654-4bf5-9eed-e2c7943084ed	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Sample	Exclude flag	Status
81665-300-02	81665030002	1 BOTTLE, GLASS in 1 CARTON (81665-300-02) / 4 mL in 1 BOTTLE, GLASS	2024-06-19	No	No	Current